| Atherosclerosis Prevention and Treatment by Inhibiting Carbamylation (02-04) (Pharmalicencing) |
|
|
Cardiovascular physiology and atherosclerosis - prevention of cardiovascular complications in patients with renal failure or increased carbamylation. |